AAPL 173.18 2.2918% MSFT 397.84 0.7343% GOOG 168.46 1.7455% GOOGL 166.62 1.6844% AMZN 184.72 3.1955% NVDA 858.11 3.3357% META 441.84 0.6034% TSLA 180.1 0.0611% TSM 136.23 0.956% LLY 755.91 -2.683% V 267.61 0.1085% AVGO 1238.3 -0.3669% JPM 191.66 -0.1042% UNH 492.97 1.8302% NVO 124.02 -4.0167% WMT 59.71 1.4613% LVMUY 164.94 0.5609% XOM 116.24 0.181% LVMHF 825.49 0.3843% MA 441.1 -0.2194%

JD Health International Inc

Healthcare US JDHIY

3.42USD
-(-%)

Last update at 2024-05-01T13:30:00Z

Day Range

3.423.42
LowHigh

52 Week Range

5.009.88
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 695.81M -901.49100M -17072.14100M -834.70000M 306.23M
Minority interest -3.12400M -0.68900M 0.53M 0.00000M 0.00000M
Net income 380.11M -1073.50700M -17234.36300M -971.80500M 214.93M
Selling general administrative 2153.53M 5536.22M 2521.93M 1247.63M 1029.13M
Selling and marketing expenses 2195.76M 2133.84M 1434.59M 746.01M 391.82M
Gross profit 9891.51M 7197.28M 4917.30M 2812.27M 1978.96M
Reconciled depreciation 140.68M 63.17M 27.22M 7.42M 6.27M
Ebit 803.11M -857.14000M -17068.60800M -797.33900M 310.77M
Ebitda 943.79M -793.97100M -17041.38700M -789.91600M 317.03M
Depreciation and amortization 140.68M 63.17M 27.22M 7.42M 6.27M
Non operating income net other - - - - -
Operating income 803.11M -857.14000M -17068.60800M -797.33900M 310.77M
Other operating expenses 46783.07M 32047.96M 19030.85M 10408.70M 7861.94M
Interest expense 9.10M 6.00M 3.42M 35.50M 0.15M
Tax provision 312.58M 171.33M 162.76M 137.10M 91.31M
Interest income 864.27M 457.57M 149.12M 31.78M 0.08M
Net interest income 855.17M 451.57M 145.70M -3.71900M -0.06600M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 312.58M 171.33M 162.76M 137.10M 91.31M
Total revenue 46736.15M 30682.27M 19382.57M 10842.14M 8169.06M
Total operating expenses 9938.43M 8562.98M 4565.58M 2378.83M 1671.84M
Cost of revenue 36844.64M 23484.99M 14465.27M 8029.87M 6190.10M
Total other income expense net -107.30100M -44.35100M -3.53300M -37.36100M -4.53600M
Discontinued operations - - - - -
Net income from continuing ops 383.23M -1072.81800M -17234.89700M -971.80500M 214.93M
Net income applicable to common shares - -1073.50700M -17234.36300M -971.80500M 214.93M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 61277.30M 48002.22M 43994.55M 8676.68M 1182.15M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 757.41M 8.61M 4.52M 2.50M 3.02M
Total liab 16492.73M 8147.63M 4743.20M 9135.71M 432.93M
Total stockholder equity 44780.25M 39853.39M 39250.84M -459.03100M 749.22M
Deferred long term liab - - - - -
Other current liab 5759.48M 2452.41M 1753.63M 1095.04M 89.57M
Common stock 0.01M 0.01M 0.01M 0.00700M 2.00M
Capital stock 0.01M 0.01M 0.01M 0.00700M 2.00M
Retained earnings -19382.06300M -19714.83900M -18616.76000M -1368.79100M -94.77000M
Other liab - 8.89M - - -
Good will - - - - -
Other assets 787.45M 979.65M 432.13M 28.39M 1.27M
Cash 18717.72M 17252.29M 32270.79M 4965.27M 16.21M
Cash and equivalents - - - - -
Total current liabilities 16356.15M 8005.03M 4681.79M 1544.88M 430.51M
Current deferred revenue - - - - -
Net debt -18518.31400M -17051.02600M -32180.81400M -4954.00900M -13.08700M
Short term debt 70.65M 67.55M 28.57M 4.85M 0.71M
Short long term debt - - - - -
Short long term debt total 199.41M 201.27M 89.98M 11.26M 3.13M
Other stockholder equity 64162.30M 59568.22M 57867.59M 909.75M 841.99M
Property plant equipment - 260.77M 115.01M 16.20M 4.37M
Total current assets 56447.16M 45705.48M 42704.77M 8624.04M 1166.34M
Long term investments - - - - -
Net tangible assets - 39828.00M 39222.35M -459.63100M 746.46M
Short term investments 28248.49M 24737.78M 8032.61M 1395.24M -
Net receivables 2727.27M 665.54M 664.46M 982.70M 31.80M
Long term debt - - - - -
Inventory 5996.27M 3041.24M 1732.39M 1278.34M 1115.30M
Accounts payable 10526.03M 5485.07M 2899.60M 444.98M 340.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 28727.07M 25473.60M 8282.98M 1422.43M 7.73M
Deferred long term asset charges - - - - -
Non current assets total 4830.14M 2296.74M 1289.78M 52.63M 15.81M
Capital lease obligations 199.41M 201.27M 89.98M 11.26M 3.13M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -4235.54100M -17247.23800M -7558.56800M -1440.90700M -7.40900M
Change to liabilities 6020.50M 2801.42M 2539.91M 151.92M 176.87M
Total cashflows from investing activities - -17752.15200M -7842.58400M -1448.62300M -13.68900M
Net borrowings -47.56400M -32.33400M -242.92000M 200.70M -2.77400M
Total cash from financing activities -925.44900M -163.65300M 32028.69M 6509.12M -2.92400M
Change to operating activities 665.08M 843.36M 945.75M 43.12M 4.03M
Net income 383.23M -1072.81800M -17234.89700M -971.80500M 214.93M
Change in cash 1465.43M -15018.49700M 27305.52M 4949.06M 8.81M
Begin period cash flow 17252.29M 32270.79M 4965.27M 16.21M 7.40M
End period cash flow 18717.72M 17252.29M 32270.79M 4965.27M 16.21M
Total cash from operating activities 5905.15M 3430.72M 3699.46M 409.47M 187.23M
Issuance of capital stock - 0.00000M 32274.05M 6310.66M 0.00000M
Depreciation 140.68M 63.17M 27.22M 7.42M 6.27M
Other cashflows from investing activities -5.40600M 5.18M -242.90600M -2.02700M -3.86400M
Dividends paid - - - - -
Change to inventory -3151.37600M -1286.16000M -522.20700M -164.02500M -232.36800M
Change to account receivables -685.07600M -331.40000M -47.65900M -3.37900M -21.32700M
Sale purchase of stock -869.03500M -126.40700M - - -
Other cashflows from financing activities -56.41400M -37.24600M 6242.70M 6509.11M -2.92400M
Change to netincome 2535.23M 2413.84M 17990.80M 1346.21M 38.83M
Capital expenditures 2272.95M 518.16M 38.79M 5.69M 2.42M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 2849.14M 2027.21M 2915.80M 27.64M -72.79700M
Stock based compensation 2104.28M 2579.71M 380.30M 52.73M 33.47M
Other non cash items 427.83M -166.55300M 17611.04M 1293.48M 5.36M
Free cash flow 3632.20M 2912.56M 3660.68M 403.78M 184.81M

Fundamentals

  • Previous Close 3.42
  • Market Cap15943.10M
  • Volume0
  • P/E Ratio62.50
  • Dividend Yield-%
  • EBITDA826.20M
  • Revenue TTM53621.27M
  • Revenue Per Share TTM17.22
  • Gross Profit TTM 7197.28M
  • Diluted EPS TTM0.08

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
JDHIY
JD Health International Inc
- -% 3.42 62.50 35.97 0.30 2.32 0.16 3.90
HCA
HCA Holdings Inc
-0.6 0.19% 308.84 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
0.08 1.06% 7.60 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA
- -% 27.91 16.76 9.62 0.42 0.79 0.78 5.31
JDHIF
JD Health International Inc
- -% 3.03 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

Profile

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. In addition, it is involved in order management, client management, and other merchants operational and maintenance support activities. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. operates as a subsidiary of JD Jiankang Limited.

JD Health International Inc

Jingdong Headquarters, Beijing, China, 101111

Key Executives

Name Title Year Born
Mr. Enlin Jin CEO & Exec. Director 1981
Mr. Dong Cao Chief Financial Officer NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).